MBM Pharmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-10-20
Share capital
20,000.00 PLN
Average employment (FTE)
21.4 (2025)
Activity description

MBM Pharma is a dietary supplement brand created by a team of pharmacists. Its range also includes medical devices and food for special medical purposes, including electrolytes, vitamin and mineral products, probiotics, and products for immune support.

Registered address
Piątkowska 214, 61-693 Poznań, Poland
Website
mbmpharma.pl
Email
Phone
Electronic delivery address
AE:PL-19151-27326-SDEHJ-13

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$9,399
Revenue structureSprzedaż usług – krajowa

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 570 days for 2021).

  • 2024not filed
  • 202328/04/2025
  • 202205/02/2024
  • 202105/02/2024
  • 202010/02/2022
  • 201915/11/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 6.13mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD -9.61kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 6.12mMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 1.87mMedianUSD 608.93kAverageUSD 11.85m

Industry

Public procurement

MBM Pharma is the contractor in 8 public sector contracts, worth USD 1.81k in total. They were signed with 6 public buyers.

SubjectAmount
Zestaw antygenów 4w1 w kierunku Sars-CoV-Grypy
$538.25
FLUORECARE COMBO TESTS
$259.99
Purchase of diagnostic tests
$96.13

Trademarks

MBM Pharma holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2018.

MarkNumberClassesStatusProtected until
MBM PHARMAZ.4841845Protected Mar 28, 2028
MarkProtected until
MBM PHARMAMar 28, 2028

Authorized Representatives

Bronisław Czerniewicz – Wice-Prezes Zarządu
Magdalena Czerniewicz – President of the Management Board

Manner of representation

Each member of the management board is authorised to submit declarations of will and sign on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Bronisław Czerniewiczage 65
40$2,701.2450%
Magdalena Czerniewiczage 59
40$2,701.2450%

Bronisław Czerniewicz and Magdalena Czerniewicz hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-05-20.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $84,047.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Pharmabestsp. z o.o.
Nutropharmasp. z o.o.
MGM Pharmasp. j.
Wellmedica Hfsp. z o.o.
Polamedicasp. z o.o.
Biodosesp. z o.o. + limited partnership
Nutramaticsp. z o.o.
M&D&M International Brandssp. z o.o.
Salvum Labsp. z o.o.
Biodosesp. z o.o.

Change history

DateEvent
2017-09-12Name change
2017-09-12PKD change
2014-10-20Entered in the register

FAQ

Last updated: 2026-10-30